TORONTO, May 4 /CNW/ - FightSMA Canada has been awarded a C$250,000 research grant from CML HealthCare of Mississauga. The Children's Hospital of Eastern Ontario (CHEO) Foundation will match the grant, providing a total of C$500,000 to advance spinal muscular atrophy (SMA) research. The multi-year grant will support investigation into "clinic-ready agents" that can increase the presence of Survivor Motor Neuron, a protein that is essential for muscle strength and is deficient in children diagnosed with SMA.

"SMA is a devastating disease," said CHEO research institute's Dr. Alex MacKenzie. "It is the number-one genetic cause of death among infants. This generous gift from CML HealthCare and the CHEO foundation will be key to moving the fight against SMA forward and will provide the thousands of children fighting this terrifying disease with hope for an effective treatment in the future," said Dr. MacKenzie.

"CML HealthCare is excited about supporting the fight against SMA," said Kent Nicholson, Executive Vice President and Chief Operating Officer. "We are very impressed and inspired by the determination and dedication of the researchers and families fighting SMA, and we are proud to be a part of the fight."

"I want to express my appreciation for the support that CML HealthCare has provided and for their continued dedication in helping us find a cure for SMA," said Tracy Lacey, President of FightSMA Canada. "CML's efforts have made our recent research funding campaign one of the most successful that we have ever had."

As a leading Canadian provider of diagnostic medical services, CML HealthCare is dedicated to providing patients with Care. Confidence. Comfort.TM The nearly 40-year-old company is one of largest providers of medical imaging services in North America and one of the largest community-based providers of laboratory testing services in Ontario.

"It is companies with vision, like CML HealthCare, that are truly changing our world," said Martha Slay, President of FightSMA. "We all benefit from their generosity and from their example."

FightSMA is an international nonprofit corporation dedicated to developing a treatment for spinal muscular atrophy (SMA). FightSMA has awarded SMA research grants to more than 40 universities and research institutions in Canada, the United States, the United Kingdom, France, and Italy.

-30-

For further information: Kent Nicholson, Executive Vice President & Chief Operating Officer, CML HealthCare Income Fund, (905) 565-0043, (905) 565-2844 fax, Internet: www.cmlhealthcare.com